Intelligent Techniques Using Molecular Data Analysis in Leukaemia: An Opportunity for Personalized Medicine Support System

Abstract

The use of intelligent techniques in medicine has brought a ray of hope in terms of treating leukaemia patients. Personalized treatment uses patient's genetic profile to select a mode of treatment. This process makes use of molecular technology and machine learning, to determine the most suitable approach to treating a leukaemia patient. Until now, no reviews have been published from a computational perspective concerning the development of personalized medicine intelligent techniques for leukaemia patients using molecular data analysis. This review studies the published empirical research on personalized medicine in leukaemia and synthesizes findings across studies related to intelligence techniques in leukaemia, with specific attention to particular categories of these studies to help identify opportunities for further research into personalized medicine support systems in chronic myeloid leukaemia. A systematic search was carried out to identify studies using intelligence techniques in leukaemia and to categorize these studies based on leukaemia type and also the task, data source, and purpose of the studies. Most studies used molecular data analysis for personalized medicine, but future advancement for leukaemia patients requires molecular models that use advanced machine-learning methods to automate decision-making in treatment management to deliver supportive medical information to the patient in clinical practice.

Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance

“…Although multiple targeted therapies are available for CML patients, it is challenging to select the best targeted therapy to each patient. Therefore, the use of intelligent techniques (e.g., artificial intelligence (AI)) [ 19 ] and the development of mathematical modeling and computational prediction methods could anticipate the underlying mechanisms of drug resistance and facilitate the design of more effective treatment strategies to improve drug efficacy [ 20 ].…”

Farmácia Colorida: Tecnologias De Saúde Para a População Indígena

“…Quanto ao local de estudo, a maioria dos artigos foram produzidos no continente MOJA et al, 2016a;MOJA et al, 2016b;BANJAR et al, 2017).…”

“…Esse processo faz uso de tecnologia molecular e software com o objetivo de fornecer informações médicas para automatizar e padronizar o atendimento na prática clínica, fornecendo o suporte direto à decisão médica e facilitando a transferência do conhecimento local para centros mais remotos e diminuindo a possibilidade de erros médicos (BANJAR et al, 2017;LIN et al, 2016).…”

EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases

“…However, big data is an emergent area in need of guidelines and general recommendations on how to move this field forward in a collaborative and ethical way. Some of the challenges presented by big data and artificial intelligence include data sources and data collection: how to collect and store the data, while guaranteeing ethics and data privacy12; how to interpret data models of complex analyses13 14; and what are the clinical implications of big data: how to go from big data to clinical decision-making 3 15 16…”